Q2 2026 results represent a cyclical peak, not a new baseline, with EPS ranging from $22.87 to $83.92 (267% peak-to-trough swing) over four years

• Q2 2026: revenue +28% YoY, EPS +92% YoY, operating margin 42.2%
• 2022: Revenue $47.4B, EPS $30.06
• 2023: Revenue $46.3B, EPS $22.87 (-24% YoY)
• 2024: Revenue $53.5B, EPS $40.54 (+77% YoY)
• 2025: Revenue $58.3B, EPS $51.32 (+27% YoY)
• Q2 2026 annualized: Revenue $68.9B, EPS $83.92 (+63% YoY)
• Forward EPS $74.03 vs Q2 annualized $83.92 — $10 gap between consensus and run-rate

↩ rebuts: “Bull's claim that Q2 represents sustainable earnings power and that estimates will rise”

Anthropic stabilization agent role captures a fraction of the headline economics — mid-single-digit cents of EPS, not a quarter-changer — with timing uncertainty repriced sharply downward

• Goldman is stabilisation agent; Morgan Stanley is lead-left
• At $2T valuation with 7% gross spread, total fees ~$14B; Goldman's stabilisation share = few hundred million in fees
• Anthropic October odds: 58% from 90% — down 32 percentage points in one week
• If Anthropic prices at $1.2T instead of $2T, stabilisation economics are 40% smaller
• No S-1 filed, no price range set — $2T valuation is aspirational

↩ rebuts: “Bull's framing of Anthropic as a 'franchise reaffirming event' and 'quarter-changer'”

Technical pattern is a distribution range with downward bias, not a 'coil' — 50 SMA rolling over, MACD still negative, RSI unconfirmed, and prior blow-off top at $1,146 followed by 15% crash in 11 sessions

• 50 SMA peaked at ~$1,050 mid-August, now at $1,039.45 — peak and rollover
• RSI at 51.43 — sitting below 50, positive divergence has not resolved within 5-10 sessions
• MACD line at -2.51 — still negative, not in bullish regime
• July 14-15 spike to $1,146 followed by 15% crash in 11 sessions — textbook blow-off top
• $1,090-$1,150 zone is major overhead supply that won't be cleared for months, if not quarters
• Lower Bollinger Band tested twice — third test breaks more often than holds

↩ rebuts: “Bull's 'coiled spring' technical framing and 'lower band held twice is structural floor' argument”

A hawkish Fed compresses equity multiples (higher discount rates) and creates two-sided NIM risk — 100bp move in funding costs = $3.87B pre-tax hit to NII

• Balance sheet: $1,442B (2022) to $2,060B (Q1 2026) = 43% expansion
• Debt/equity at 7.25x
• Long-term debt $387B+
• 100bp move in funding costs = $3.87B pre-tax hit = $9/share in earnings at risk
• Polymarket prices 70% odds of at least one 2026 hike and 93% odds of no cuts

↩ rebuts: “Bull's 'hawkish Fed is unalloyed good' argument”

The 'buyback floor' is fiction — buybacks slow in sell-offs to preserve capital ratios (2008 and 2020 playbook), and deploying $31B at potentially peak-cycle prices destroys capital if price falls

• Treasury stock balance grew from $94.6B to $125.9B — $31B deployed
• 12% share count reduction over 3+ years is ~4%/year — modest EPS tailwind
• Buybacks did ~200-300bps of EPS lift; operating performance did the rest
• Management will not buy $5B/quarter in a free-fall — they'll hoard capital

↩ rebuts: “Bull's 'structural price floor' framing from $5B/quarter buybacks”

Competitive moat is narrowing — equities trading share bleeding to systematic-prop complex, Morgan Stanley is lead-left on Anthropic (relegation, not reaffirmation), and internal AI warning signals franchise-level concern about human judgment erosion

• Citadel Securities, Optiver, Hudson River Trading, Jane Street systematically taking equities share from bulge-bracket banks
• Morgan Stanley is lead-left on Anthropic — not Goldman
• Chris Churchman (senior partner) publicly questioning whether AI is structurally degrading the human-capital base that defines GS's value proposition
• Bellevue headcount expansion ~1%/year — barely participation in AI hiring race

↩ rebuts: “Bull's framing of AI cycle as GS's structural advantage”

Valuation at 73rd percentile of 52-week range offers poor risk/reward: ~11% upside to high, ~29% downside to low; P/B 2.86x is expensive if ROE normalizes to 13-14%

• Price $1,036 = 73rd percentile of 52-week range ($738 low, $1,154 high)
• Upside to 52-week high: $118 (11%)
• Downside to 52-week low: $298 (29%)
• Forward P/E 14x prices in 14% growth; bull claims 18-22%
• P/B at 2.86x fine for 17% ROE — but if ROE drops to 13-14% on revenue normalization to $15B/quarter, 2.86x P/B becomes expensive

↩ rebuts: “Bull's '14x forward P/E is attractive' argument”

Bear case risks are disjunctive (any one delivers 5%+ drawdown), not conjunctive — unlike bull case which requires multiple things to go right and a close above $1,043 on volume that tape has failed to deliver for two weeks

• Anthropic slipping to Q1 2027 alone = 5-8% downside
• Hawkish Fed surprise (rate hike with hawkish dot plot) = 3-5% downside
• Any credit event or recession scare = 10-15% downside given 1.28 beta
• Clean break of $1,000 = measured move to $940 (200 SMA) = 5-10% more downside
• Bull's '3:1 to upside' requires close above $1,043 on volume — failed for two weeks
• Realistic target on break of $1,043 is $1,058 (not $1,146) — only 2% upside

↩ rebuts: “Bull's 'asymmetry favoring longs' and '3:1 risk/reward' framing”

Downside risks include 1.28 beta, $513B in trading securities (25% of assets) with mark-to-market exposure, negative operating cash flow tying earnings to capital-markets health, and regulatory risk from Basel III endgame

• Beta 1.28: Any S&P -5% = GS -6.4%
• Trading securities $513B = 25% of total assets — direct mark-to-market exposure
• Long-term debt $387B: 100bp move = $3.87B pre-tax hit
• Negative OCF: structural but cyclical, ties earnings to capital-markets health
• Regulatory: Basel III endgame, capital surcharges could compress ROE 100-200bps
• Oil to $120 = market drawdown; FICC benefits but equities franchise bleeds
• ZERO Reddit mentions in 7 days — no crowd to push the next leg